Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors

Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors

Abstract. Background:. Response to immune checkpoint inhibitors (ICIs) is affected by multiple factors. This study aimed to explore whether sites of metastasis are associated with clinical outcomes of ICIs in advanced non-small-cell lung cancer (NSCLC) patients. Methods:. The data of NSCLC patients...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Jiayi Deng, Ming Gao, Qing Gou, Chongrui Xu, Honghong Yan, Mingyi Yang, Jiakang Li, Xiaorong Yang, Xuewu Wei, Qing Zhou, Peifang Wei
التنسيق: مقال
اللغة:English
منشور في: Wolters Kluwer 2022-06-01
سلاسل:Chinese Medical Journal
الوصول للمادة أونلاين:http://journals.lww.com/10.1097/CM9.0000000000002217

الانترنت

http://journals.lww.com/10.1097/CM9.0000000000002217

مواد مشابهة